PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24436372-8	2014	As a final translational approach, administration of a TLR9 agonist (type B CpG oligodeoxynucleotide 1668) to ApoE(-/-) mice resulted in a reduction of lesion severity.	Oligodeoxyribonucleotides	80-100	apolipoprotein E	Mus musculus	110-114	
18502445-0	2008	Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance.	Oligodeoxyribonucleotides	12-33	apolipoprotein E	Mus musculus	61-65